AVITA Medical, Inc.
RCEL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 28.1% | 45.7% | 4.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 85.8% | 84.5% | 82.4% | 81.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -86.1% | -66.9% | -75.7% | -73.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -96.3% | -70.6% | -77.5% | -76.1% |
| EPS Diluted | -2.39 | -1.4 | -1.57 | -1.03 |
| % Growth | -70.7% | 10.8% | -52.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |